Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '25 Aug 12, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	10	6	17	22	-
Market Cap Growth	-64.76%	-64.76%	-25.35%	-	-
Enterprise Value	9	5	14	18	-
Last Close Price	0.39	0.31	1.73	4.68	-
PB Ratio	2.46	1.48	1.13	3.87	-
P/TBV Ratio	2.46	1.48	1.13	3.87	-
Debt / Equity Ratio	-	-	0.01	0.02	-
Quick Ratio	1.01	1.01	1.01	1.70	10.99
Current Ratio	1.01	1.01	1.02	1.99	12.26
Return on Equity (ROE)	-125.79%	-125.79%	-39.99%	-159.67%	-
Return on Assets (ROA)	-68.15%	-68.15%	-22.61%	-56.67%	-
Return on Capital (ROIC)	-78.86%	-78.86%	-26.79%	-73.72%	-
Earnings Yield	-115.33%	-191.64%	-24.65%	-24.20%	-
FCF Yield	-15.89%	-26.41%	-46.94%	-14.13%	-
Buyback Yield / Dilution	-25.45%	-25.45%	-93.32%	-110.49%	-

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.